Endpoint definition
↥Name | DRUGADVERS_APLAST_ANAEM |
---|---|
Long name | Drug-induced aplastic anaemia |
Hospital Discharge registry | ICD-10: D611 |
Level in the ICD-hierarchy | C |
First defined in version | DF5 |
Name | DRUGADVERS_APLAST_ANAEM |
---|---|
Long name | Drug-induced aplastic anaemia |
Hospital Discharge registry | ICD-10: D611 |
Level in the ICD-hierarchy | C |
First defined in version | DF5 |
All | Female | Male | |
---|---|---|---|
Number of individuals | 20 | 12 | 8 |
Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
Mean age at first event (years) | 59.21 | 58.11 | 60.85 |
Case fatality at 5-years (%) | 40.00 | 41.67 | 37.50 |
All | Female | Male | |
---|---|---|---|
Median nb. of events per indiv. | 1.0 | 1.0 | 1.0 |
Recurrence at 6 months (%) | 15.00 | 25.00 | - |
before Drug-induced aplastic anaemia
after Drug-induced aplastic anaemia
Loading survival analyses plot…
Loading survival analyses table…